Journal
PEPTIDES
Volume 28, Issue 7, Pages 1344-1350Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.peptides.2007.06.014
Keywords
apoptosis human leukemia k562 cells; cyclic lipopeptide (CLP); anti-tumor
Ask authors/readers for more resources
A new cyclic lipopeptide (CLP) purified from Bacillus subtilis natto T-2 dose dependently inhibited growth in human leukemia K562 cells. The results of fluorescent staining indicated that CLP brought about apoptosis in K562 cells. Flow cytometric analysis also demonstrated that CLP caused dose-dependent apoptosis of K562 cells through cell arrest at G1 phase. Western blotting revealed that CLP-induced apoptosis in K562 cells was associated with caspase-3 and poly(ADP-ribose)polymerase (PARP) protein. It is estimated that CLP inhibited proliferation in K562 cells by inducing apoptosis. (c) 2007 Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available